4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
enVVeno Medical Corporation (NVNO) operates in the Medical Devices industry and is headquartered in Irvine, United States with about 33 employees. Its market capitalization is roughly $7 million. In the fiscal year ended 2025-12-31, NVNO reported $0M in revenue and ($20M) in net income.
enVVeno Medical Corporation, a medical device company, focuses on the development of bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous disease in the United States.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($21M) | ($24M) | ($25M) | ($25M) | — |
| Net Income | ($20M) | ($22M) | ($24M) | ($25M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M |
| Operating Income (EBIT) | ($4M) | ($4M) | ($5M) | ($7M) | ($5M) |
| Net Income | ($4M) | ($4M) | ($4M) | ($7M) | ($4M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $30M | $45M | $49M | $42M | — |
| Total Liabilities | $2M | $3M | $2M | $3M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive NVNO viewer.
About TickerBase · Data methodology & sources